Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IG5E
|
||||
Former ID |
DNC009158
|
||||
Drug Name |
2,5'-dichloro-5'-deoxy-N6-cyclopentyladenosine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530035] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H19Cl2N5O3
|
||||
Canonical SMILES |
C1CCC(C1)NC2=NC(=NC3=C2N=CN3C4C(C(C(O4)CCl)O)O)Cl
|
||||
InChI |
1S/C15H19Cl2N5O3/c16-5-8-10(23)11(24)14(25-8)22-6-18-9-12(19-7-3-1-2-4-7)20-15(17)21-13(9)22/h6-8,10-11,14,23-24H,1-5H2,(H,19,20,21)/t8-,10-,11-,14-/m1/s1
|
||||
InChIKey |
GWUOJELSUSGGDU-IDTAVKCVSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530035] | |
Adenosine A1 receptor | Target Info | Inhibitor | [530035] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [530035] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [530035] | ||
KEGG Pathway | cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.